CYLD antibody (AA 618-956) (Cy3)
Quick Overview for CYLD antibody (AA 618-956) (Cy3) (ABIN7982573)
Target
See all CYLD AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 618-956
-
Purpose
- Anti-CYLD Antibody Cy3 Conjugated
-
Specificity
- No cross reactivity with other proteins.
-
Cross-Reactivity (Details)
- No cross-reactivity with other proteins
-
Predicted Reactivity
- Human CYLD shares 97.6%,97.9% amino acid (aa) sequence identity with mouse,rat CYLD,respectively.
-
Purification
- Immunogen affinity purified.
-
Immunogen
- E.coli-derived human CYLD recombinant protein (Position: D618-K956). Human CYLD shares 97.6% and 97.9% amino acid (aa) sequence identity with mouse and rat CYLD, respectively.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Flow Cytometry, 1-3 μg/1x106 cells
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Expiry Date
- 12 months
-
-
- CYLD (Cylindromatosis (Turban Tumor Syndrome) (CYLD))
-
Alternative Name
- CYLD
-
Background
-
Background: CYLD is localized on the long arm of chromosome 16. This gene encodes a cytoplasmic protein with three cytoskeletal-associated protein-glycine-conserved (CAP-GLY) domains that functions as a deubiquitinating enzyme. Mutations in this gene have been associated with cylindromatosis, multiple familial trichoepithelioma, and Brooke-Spiegler syndrome. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.
Gene Full Name: CYLD lysine 63 deubiquitinase
Sequence Similarities: Belongs to the peptidase C19 family.
-
Gene ID
- 1540
-
UniProt
- Q9NQC7
-
Pathways
- Apoptosis, Activation of Innate immune Response
Target
-